Skip to main content

Advertisement

Articles

Page 4 of 45

  1. Runt-related transcription factor 1 (RUNX1) plays the roles of an oncogene and an anti-oncogene in epithelial tumours, and abnormally elevated RUNX1 has been suggested to contribute to the carcinogenesis of co...

    Authors: Qingyuan Li, Qiuhua Lai, Chengcheng He, Yuxin Fang, Qun Yan, Yue Zhang, Xinke Wang, Chuncai Gu, Yiqing Wang, Liangying Ye, Lu Han, Xin Lin, Junsheng Chen, Jianqun Cai, Aimin Li and Side Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:334

    Content type: Research

    Published on:

  2. Immunotherapeutic approaches designed to augment T and B cell mediated killing of tumor cells has met with clinical success in recent years suggesting tremendous potential for treatment in a broad spectrum of ...

    Authors: Lawrence H. Cheung, Yunli Zhao, Ana Alvarez-Cienfuegos, Khalid A. Mohamedali, Yu J. Cao, Walter N. Hittelman and Michael G. Rosenblum

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:332

    Content type: Research

    Published on:

  3. In the original publication of this article [1], the Gene Expression Omnibus (GEO) accession code GSE79772 is wrong. The correct accession code should be GSE86213.

    Authors: Yinfang Wang, Yanli Hou, Weiwei Zhang, Angel A. Alvarez, Yongrui Bai, Bo Hu, Shi-Yuan Cheng, Kun Yang, Yanxin Li and Haizhong Feng

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:331

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:147

  4. RelA/p65 a crucial member of NF-κB signaling pathway plays diverse role in mediating oncogenesis. Limited knowledge prevails on the mechanistic insights of RelA gene regulation. RNA helicase p68 apart from bei...

    Authors: Veenita Khare, Shaheda Tabassum, Uttara Chatterjee, Sandip Chatterjee and Mrinal K. Ghosh

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:330

    Content type: Research

    Published on:

  5. Kinesins play important roles in the development and progression of many human cancers. The functions and underlying mechanisms of kinesin family member C1 (KIFC1), a member of the kinesin-14 family, in the pa...

    Authors: Kai Teng, Shi Wei, Chi Zhang, Jiewei Chen, Jinbin Chen, Kanghua Xiao, Jun Liu, Miaomiao Dai, Xinyuan Guan, Jingping Yun and Dan Xie

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:329

    Content type: Research

    Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2019 38:442

  6. Tumor heterogeneity results in differential response to therapy due to the existence of plastic tumor cells, called cancer stem cells (CSCs), which exhibit the property of resistance to therapy, invasion and m...

    Authors: Pavana Thomas, Annapurna Pranatharthi, Cecil Ross and Sweta Srivastava

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:328

    Content type: Review

    Published on:

  7. Malignant tumors are often multifactorial. Epidemiological studies have shown that hyperglycemia raises the prevalence and mortality of certain malignancies, like breast, liver, bladder, pancreatic, colorectal...

    Authors: Wenjie Li, Xuehui Zhang, Hui Sang, Ying Zhou, Chunyu Shang, Yongqing Wang and Hong Zhu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:327

    Content type: Review

    Published on:

  8. Prostate cancer (PCa) is the second leading cause of cancer-related death in the Western population. The use in oncology of positron emission tomography/computed tomography (PET/CT) with emerging radiopharmace...

    Authors: B. Frigerio, S. Morlino, E. Luison, E. Seregni, A. Lorenzoni, A. Satta, R. Valdagni, A. Bogni, C. Chiesa, M. Mira, S. Canevari, A. Alessi and M. Figini

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:326

    Content type: Research

    Published on:

  9. Sodium/iodide symporter (NIS)-mediated iodide uptake plays an important physiological role in regulating thyroid gland function, as well as in diagnosing and treating Graves’ disease and thyroid cancer. High-m...

    Authors: Wenwen Chai, Fanghua Ye, Li Zeng, Yanling Li and Liangchun Yang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:325

    Content type: Research

    Published on:

  10. The human ether a-go-go-related gene 1 (HERG1) is involved in tumor progression; however, its role in esophageal squamous cell carcinoma (ESCC) is not well studied. This study investigated HERG1 function in ES...

    Authors: Hongqiang Wang, Xuchun Yang, Yan Guo, Lin Shui, Shi Li, Yifeng Bai, Yu Liu, Ming Zeng and Jianling Xia

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:324

    Content type: Research

    Published on:

  11. Numerous studies have presented that curcumin could have a positive effect in the prevention of cancer and then in tumor therapy. Several hypotheses have highlighted that curcumin could decreases tumor growth ...

    Authors: Alexandre Vallée, Yves Lecarpentier and Jean-Noël Vallée

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:323

    Content type: Review

    Published on:

  12. CDK4/6 inhibitors are a promising treatment strategy in tumor therapy but are hampered by resistance mechanisms. This study was performed to reveal predictive markers, mechanisms of resistance and to develop r...

    Authors: Zhichao Tong, Anuja Sathe, Benedikt Ebner, Pan Qi, Christian Veltkamp, Juergen E. Gschwend, Per Sonne Holm and Roman Nawroth

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:322

    Content type: Research

    Published on:

  13. Recurrence and metastasis are the leading causes of tumour-related death in patients with oesophageal squamous cell carcinoma (ESCC). Tumour-infiltrating natural killer cells (NK cells) display powerful cytoto...

    Authors: Jian Wu, Feng-xia Gao, Chao Wang, Mei Qin, Fei Han, Tao Xu, Zhi Hu, Yang Long, Xue-mei He, Xin Deng, De-lian Ren and Tian-yang Dai

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:321

    Content type: Research

    Published on:

  14. Acquired resistance remains a limitation of the clinical use of 5-fluorouracil (5-FU). Because exosomes, are important vesicles participating in intercellular communication, their contribution to the developme...

    Authors: Qian Zhang, Rui-Xian Liu, Ka-Wo Chan, Jiancong Hu, Jingdan Zhang, Lili Wei, Huiliu Tan, Xiangling Yang and Huanliang Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:320

    Content type: Research

    Published on:

  15. Despite a good and overall prognosis, papillary thyroid cancer (PTC) can still affect the quality of life of many patients, and can even be life-threatening due to its invasiveness and metastasis. Emerging stu...

    Authors: Yao Yao, Xinyuan Chen, Hong Yang, Wei Chen, Yichun Qian, Zhongyi Yan, Tian Liao, Weiping Yao, Wenlan Wu, Tonghua Yu, Yun Chen and Yuan Zhang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:318

    Content type: Research

    Published on:

  16. Molecular markers for prostate cancer (PCa) are required to improve the early definition of patient outcomes. Atypically large extracellular vesicles (EVs), referred as “Large Oncosomes” (LO), have been identi...

    Authors: Chiara Ciardiello, Alessandra Leone, Paola Lanuti, Maria S. Roca, Tania Moccia, Valentina R. Minciacchi, Michele Minopoli, Vincenzo Gigantino, Rossella De Cecio, Massimo Rippa, Lucia Petti, Francesca Capone, Carlo Vitagliano, Maria R. Milone, Biagio Pucci, Rita Lombardi…

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:317

    Content type: Research

    Published on:

  17. Sorafenib is the first-line treatment for advanced-stage hepatocellular carcinoma (HCC). Several studies have shown that the up-regulation of β-catenin plays a role in sorafenib resistance in HCC; however, the...

    Authors: Ling Deng, Jingyuan Sun, Xiaohui Chen, Li Liu and Dehua Wu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:316

    Content type: Research

    Published on:

  18. Adenosine deaminases acting on RNA (ADARs) are involved in adenosine-to-inosine (A-to-I) editing and implicated in tumorigenesis and prognosis. Emerging evidence has indicated that ADAR1, an ADAR family member...

    Authors: Xue Liu, Yu Fu, Jiadong Huang, Meng Wu, Zhenxing Zhang, Rongyao Xu, Ping Zhang, Shouwei Zhao, Laikui Liu and Hongbing Jiang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:315

    Content type: Research

    Published on:

  19. IDO1 (Indoleamine 2,3-dioxygenase 1) inhibits host anti-tumor immune response by exhausting tryptophan in tumor microenvironment, but the pathogenic mechanisms of IDO1 in gastric cancer (GC) cells need to be f...

    Authors: Zhen Xiang, Jun Li, Shuzheng Song, Jiexuan Wang, Wei Cai, Wenjun Hu, Jun Ji, Zhenggang Zhu, Lu Zang, Ranlin Yan and Yingyan Yu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:314

    Content type: Research

    Published on:

  20. Breast cancer is the most common malignancy in women worldwide. Among the breast cancer subtypes, triple-negative breast cancer (TNBC) is the most aggressive and the most difficult to treat. One of the master ...

    Authors: Rossella Zanin, Silvia Pegoraro, Gloria Ros, Yari Ciani, Silvano Piazza, Fleur Bossi, Roberta Bulla, Cristina Zennaro, Federica Tonon, Dejan Lazarevic, Elia Stupka, Riccardo Sgarra and Guidalberto Manfioletti

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:313

    Content type: Research

    Published on:

  21. Glioblastoma is the most aggressive and most lethal primary brain tumor in the adulthood. Current standard therapies are not curative and novel therapeutic options are urgently required. Present knowledge sugg...

    Authors: F. Berardinelli, M. Tanori, D. Muoio, M. Buccarelli, A. di Masi, S. Leone, L. Ricci-Vitiani, R. Pallini, M. Mancuso and A. Antoccia

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:311

    Content type: Research

    Published on:

  22. Exosomes from cancer cells or immune cells, carrying bio-macromolecules or microRNAs (miRNAs), participate in tumor pathogenesis and progression by modulating microenvironment. Our study aims to investigate th...

    Authors: Zi Yin, Tingting Ma, Bowen Huang, Lehang Lin, Yu Zhou, Jinhai Yan, Yiping Zou and Sheng Chen

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:310

    Content type: Research

    Published on:

  23. Triple negative breast cancer (TNBC) is a breast cancer subgroup characterized by a lack of hormone receptors’ expression and no HER2 overexpression. These molecular features both drastically reduce treatment ...

    Authors: Matilde Clarissa Malfatti, Lorenzo Gerratana, Emiliano Dalla, Miriam Isola, Giuseppe Damante, Carla Di Loreto, Fabio Puglisi and Gianluca Tell

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:309

    Content type: Research

    Published on:

  24. At present, it is generally believed that leukemia stem cells are the source of AML, so the killing of leukemia stem cells has become important. Previous studies have suggested that HHT combined with ATO can s...

    Authors: Ming Tan, Qian Zhang, Xiaohong Yuan, Yuanzhong Chen and Yong Wu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:308

    Content type: Research

    Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2019 38:407

  25. We reported previously that phenethyl isothiocyanate (PEITC), a dietary compound, can reactivate p53R175H mutant in vitro and in SK-BR-3 (p53R175H) breast xenograft model resulting in tumor inhibition. Because of...

    Authors: Monika Aggarwal, Rahul Saxena, Nasir Asif, Elizabeth Sinclair, Judy Tan, Idalia Cruz, Deborah Berry, Bhaskar Kallakury, Quynhchi Pham, Thomas T. Y. Wang and Fung-Lung Chung

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:307

    Content type: Research

    Published on:

  26. HER2-overexpressing metastatic breast cancers are challenging practice in oncology when they become resistant to anti-HER2 therapies such as trastuzumab. In these clinical situations, HER2-overexpression persi...

    Authors: Toni Nunes, Thomas Pons, Xue Hou, Khanh Van Do, Benoît Caron, Marthe Rigal, Mélanie Di Benedetto, Bruno Palpant, Christophe Leboeuf, Anne Janin and Guilhem Bousquet

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:306

    Content type: Research

    Published on:

  27. The mechanism underlying breast cancer stem cell (BCSCs) characteristics remains to be fully elucidated. Accumulating evidence implies that long noncoding RNAs (lncRNAs) play a pivotal role in regulating BCSCs...

    Authors: Ang Zheng, Xinyue Song, Lin Zhang, Lin Zhao, Xiaoyun Mao, Minjie Wei and Feng Jin

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:305

    Content type: Research

    Published on:

  28. Esophageal squamous cell carcinoma (ESCC) is the most difficult subtype of esophageal cancer to treat due to the paucity of effective targeted therapy. ESCC is believed to arise from cancer stem cells (CSCs) t...

    Authors: Yue Zhao, Ji Zhu, Bowen Shi, Xinyu Wang, Qijue Lu, Chunguang Li and Hezhong Chen

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:304

    Content type: Research

    Published on:

  29. Gut microbiota and the tumor microenvironment are thought to be critical factors that modulate the processes of liver diseases, including hepatocellular carcinoma (HCC). Interleukin-25 (IL-25) promotes type 2 ...

    Authors: Qiao Li, Lei Ma, Shunli Shen, Yu Guo, Qinghua Cao, Xiuqin Cai, Juan Feng, Yuan Yan, Tianyu Hu, Shiya Luo, Lin Zhou, Baogang Peng, Zhonghan Yang and Yunpeng Hua

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:303

    Content type: Research

    Published on:

  30. Diabetes is recognized to be a risk factor of pancreatic cancer, but the mechanism has not been fully elucidated. Sterol regulatory element binding protein 1 (SREBP1) is an important transcription factor invol...

    Authors: Cancan Zhou, Weikun Qian, Jie Li, Jiguang Ma, Xin Chen, Zhengdong Jiang, Liang Cheng, Wanxing Duan, Zheng Wang, Zheng Wu, Qingyong Ma and Xuqi Li

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:302

    Content type: Research

    Published on:

  31. Colorectal cancer (CRC) remains the fourth most common cause of cancer-related mortality worldwide. We aimed to identify key molecules and signalling pathways mediating CRC growth and metastasis. Polypyrimidin...

    Authors: Pingfu Hou, Fang Chen, Hongmei Yong, Tian Lin, Jingjing Li, Yu Pan, Tao Jiang, Minle Li, Yansu Chen, Jun Song, Junnian Zheng and Jin Bai

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:301

    Content type: Research

    Published on:

  32. Cancer is fundamentally a deregulation of cell growth and proliferation. Cancer cells often have perturbed metabolism that leads to the alteration of metabolic intermediates. Dehydrogenase/reductase member 2 (...

    Authors: Xiangjian Luo, Namei Li, Xu Zhao, Chaoliang Liao, Runxin Ye, Can Cheng, Zhijie Xu, Jing Quan, Jikai Liu and Ya Cao

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:300

    Content type: Research

    Published on:

  33. Programmed death 1 (PD-1) blockade has great effect in the prevention of oral precancerous lesions, but the drug resistance has also been observed. The determinants of immune resistance during the malignant tr...

    Authors: Liling Wen, Huanzi Lu, Qiusheng Li, Qunxing Li, Shuqiong Wen, Dikan Wang, Xi Wang, Juan Fang, Jun Cui, Bin Cheng and Zhi Wang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:299

    Content type: Research

    Published on:

  34. Gliomas are the most common primary tumors in central nervous system. Despite advances in diagnosis and therapy, the prognosis of glioma remains gloomy. Autophagy is a cellular catabolic process that degrades ...

    Authors: Zhi-peng Wen, Wen-jing Zeng, Yan-hong Chen, He Li, Jie-ya Wang, Quan Cheng, Jing Yu, Hong-hao Zhou, Zheng-zheng Liu, Jian Xiao and Xiao-ping Chen

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:298

    Content type: Research

    Published on:

  35. Ubiquitin-like protein 4A (UBL4A) plays a significant role in protein metabolism and the maintenance of cellular homeostasis. In cancer, UBL4A represses tumorigenesis and is involved in various signaling pathw...

    Authors: Hongze Chen, Le Li, Jisheng Hu, Zhongjie Zhao, Liang Ji, Chundong Cheng, Guangquan Zhang, Tao zhang, Yilong Li, Hua Chen, Shangha Pan and Bei Sun

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:297

    Content type: Research

    Published on:

  36. Karyopherin nuclear transport receptors play important roles in tumour development and drug resistance and have been reported as potential biomarkers and therapeutic targets for tumour treatment. However, IPO5...

    Authors: Wenjuan Zhang, Yanxia Lu, Xiaomin Li, Jianming Zhang, Weihao Lin, Wei Zhang, Lin Zheng and Xuenong Li

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:296

    Content type: Research

    Published on:

  37. High-grade endometrioid and serous endometrial cancers (ECs) are an aggressive subtype of ECs without effective therapies. The reciprocal communication between tumor cells and their surrounding microenvironmen...

    Authors: Peixin Dong, Ying Xiong, Junming Yue, Daozhi Xu, Kei Ihira, Yosuke Konno, Noriko Kobayashi, Yukiharu Todo and Hidemichi Watari

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:295

    Content type: Research

    Published on:

  38. In the era of personalized therapy, functional annotation of less frequent genetic aberrations will be instrumental in adapting effective therapeutic in clinic. Overexpression of Melanoma associated antigen A3...

    Authors: Biswajit Das and Shantibhusan Senapati

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:294

    Content type: Research

    Published on:

  39. Signal transducer and activator of transcription 3 (STAT3) is an oncogene, which upregulates in approximately 70% of human cancers. Autophagy is an evolutionarily conserved process which maintains cellular hom...

    Authors: Shichong Lin, Lehe Yang, Yulei Yao, Lingyuan Xu, Youqun Xiang, Haiyang Zhao, Liangxing Wang, Zhigui Zuo, Xiaoying Huang and Chengguang Zhao

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:293

    Content type: Research

    Published on:

  40. Bladder cancer progression has been associated with dysfunctional repair of double-strand breaks (DSB), a deleterious type of DNA lesions that fuel genomic instability. Accurate DSB repair relies on two distin...

    Authors: Christin Richter, Stephan Marquardt, Fanghua Li, Alf Spitschak, Nico Murr, Berdien A. H. Edelhäuser, George Iliakis, Brigitte M. Pützer and Stella Logotheti

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:292

    Content type: Research

    Published on:

  41. Glioma is one of the most aggressive malignant brain tumors which is characterized with highly infiltrative growth and poor prognosis. NKAP (NF-κB activating protein) is a widely expressed 415-amino acid nucle...

    Authors: Guangyan Gu, Taihong Gao, Lu Zhang, Xiuyang Chen, Qi Pang, Yanan Wang, Dan Wang, Jie Li and Qian Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:291

    Content type: Research

    Published on:

  42. This commentary wishes to highlight the latest discoveries in the mutant p53 field that have been discussed in the 8th p53 Mutant Workshop 2019, held in Lyon. TP53 mutant (mutp53) proteins are involved in the pat...

    Authors: Silvia Di Agostino, Giulia Fontemaggi, Sabrina Strano, Giovanni Blandino and Gabriella D’Orazi

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:290

    Content type: Commentary

    Published on:

  43. Glioblastoma (GBM) cells with stem cell-like properties are called glioma stem cells (GSCs). GSCs display highly treatment resistance and are responsible for tumor recurrence. Napabucasin (BBI608), a novel sma...

    Authors: Dongfeng Han, Tianfu Yu, Nan Dong, Bo Wang, Fei Sun and Dehua Jiang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:289

    Content type: Research

    Published on:

  44. In the original publication of this article [1], there is a mistake in Figure 7. The tags of TGF-beta and calycosin in Western blotting electrophoresis images are reversed.

    Authors: Qun Wang, Weijun Lu, Tao Yin and Li Lu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:288

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:240

  45. Drug resistance represents the major reason of pharmacological treatment failure. It is supported by a broad spectrum of mechanisms, whose molecular bases have been frequently correlated to aberrant protein ph...

    Authors: Christian Borgo and Maria Ruzzene

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:287

    Content type: Review

    Published on:

  46. CDK5, an atypical member of the CDK family, play a significant role in the tumorigenesis of multiple organ, but CDK5 and its substrates in genesis and development of HCC is still unclear.

    Authors: Fuqiang Wang, Wenxing Zhao, Yuehong Gao, Jiechao Zhou, Huifang Li, Guanyun Zhang, Dong Guo, Chengrong Xie, Jie Li, Zhenyu Yin and Jie Zhang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:286

    Content type: Research

    Published on:

  47. Anti-angiogenic therapies demonstrate anti-tumor effects by decreasing blood supply to tumors and inhibiting tumor growth. However, anti-angiogenic therapy may leads to changes in tumor microenvironment and in...

    Authors: Weilong Zhong, Wendong Yang, Yuan Qin, Wenguang Gu, Yinyin Xue, Yuanhao Tang, Hengwei Xu, Hongzhi Wang, Chao Zhang, Changhua Wang, Bo Sun, Yanrong Liu, Huijuan Liu, Honggang Zhou, Shuang Chen, Tao Sun…

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:285

    Content type: Research

    Published on:

  48. In the original publication of this article [1], there are two errors.

    Authors: Xihong Liu, Peiyuan Zhao, Xiujuan Wang, Lei Wang, Yingjun Zhu, Yadi Song and Wei Gao

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:284

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:184

  49. Mucins are key components of the mucosal barrier in the stomach that protects epithelia from carcinogenic effects of chronic inflammation. Analysis of The Cancer Genome Atlas database indicated that mucin-17 (...

    Authors: Bing Yang, Aiwen Wu, Yingqi Hu, Cuijian Tao, Ji Ming Wang, Youyong Lu and Rui Xing

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:283

    Content type: Research

    Published on:

  50. Lung cancer is the most common cause of cancer-related mortality worldwide despite diagnostic improvements and the development of targeted therapies, notably including epidermal growth factor receptor (EGFR) t...

    Authors: Yi-Ying Wu, Hung-Chang Wu, Jia-En Wu, Kuo-Yen Huang, Shuenn-Chen Yang, Si-Xuan Chen, Chao-Jung Tsao, Keng-Fu Hsu, Yuh-Ling Chen and Tse-Ming Hong

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:282

    Content type: Research

    Published on:

Annual Journal Metrics

Advertisement